How to appeal a UnitedHealthcare asthma & severe allergies denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

UnitedHealthcare-specific note: UHC's parent UnitedHealth Group owns Optum (PBM Optum Rx) and Surest. Surest plans have different cost-sharing rules. State complaints flow to state insurance department + DOL/EBSA for self-funded.

What UnitedHealthcare's policy requires for asthma & severe allergies

Cited policy: OptumRx PA — Xolair (Omalizumab) for Severe Allergic Asthma + Food Allergy

Age >=6 asthma / >=1 food allergy. Perennial aeroallergen sensitivity (positive skin test or specific IgE). Total IgE 30-1500 IU/mL per dosing table. Inadequately controlled on medium-to-high-dose ICS+LABA. Documented exacerbations.

How UnitedHealthcare denies asthma & severe allergies — and how to counter it

Where UnitedHealthcare pushes back: 1) IgE level outside dosing table; 2) Insufficient severity; 3) For food allergy — limited sensitization documentation.

Counter-arguments that hold up: Cite Xolair PI dosing table + INNOVATE Allergy 2005 + EXTRA Ann Intern Med 2011 + PROSE JACI 2015. Asthma approval Jun 20, 2003. Food allergy approval Feb 16, 2024 (cite OUtMATCH NEJM 2024). GINA 2024 Step 5; NAEPP 2020 conditional recommendation.

What UnitedHealthcare typically denies for asthma & severe allergies

Across UnitedHealthcare's commercial and Medicare books, denials cluster around a small number of patterns. For asthma & severe allergies, expect:

• GLP-1 weight-loss exclusion
• Out-of-network reduction citing UCR
• Step therapy on biologics
• Prior auth denied for advanced imaging
• Quantity limits on specialty drugs

Treatments most often denied in this category

These are the asthma & severe allergies treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Xolair
• Dupixent (asthma)
• Nucala
• Fasenra
• Cinqair
• Tezspire

How to submit the appeal to UnitedHealthcare

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document UnitedHealthcare cited in the denial.
3. File the appeal through UnitedHealthcare's portal (members: https://www.myuhc.com ; providers: https://www.uhcprovider.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In MN, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See UnitedHealthcare's prior-authorization criteria by drug: UnitedHealthcare PA criteria on ApprovalHelp.